American pharmaceutical company. Its products range from covid-19 vaccines to Viagra. In the third quarter of 2025 Pfizer reported year-on-year declines in sales and earnings. In November 2025 it was locked in a bidding war with Novo Nordisk over Metsera, a developer of anti-obesity drugs, for which Pfizer raised its offer from $7bn in September to $10bn. Pfizer won. In May 2025 Pfizer agreed to pay $1.25bn in fees to 3SBio, a Chinese biotech firm, for the rights to manufacture and sell an experimental cancer drug outside China, if approved.
You may already be a loser.